Press Releases

Press Releases

Visit Haemonetics Newsroom

 

We welcome you to the OpSens, now a part of Haemonetics, Newsroom. Thank you for your interest in our Company.

Through this website you can find comprehensive and detailed information related to OpSens, including financial data prior to our acquisition by Haemonetics Corporation in December 2023. For up-to-date financial information about Haemonetics, please go to the Haemonetics Newsroom linked above.

Press releases 2023

Haemonetics Completes Acquisition of OpSens
December 12, 2023
Read more
OpSens Receives Final Order for Arrangement with Haemonetics
December 8, 2023
Read more
OpSens’ Shareholders Approve Arrangement With Haemonetics
December 1, 2023
Read more
OpSens Obtains Regulatory Clearance of Arrangement in the United States and Canada; Regulatory Approvals Condition Satisfied
November 28, 2023
Read more
OpSens Announces Fourth Quarter and Fiscal Year 2023 Financial Results
November 22, 2023
Read more
Independent Proxy Advisory Firm ISS Recommends Shareholders Vote “FOR” OpSens Inc. Plan of Arrangement with Haemonetics Corporation
November 13, 2023
Read more
OpSens Receives Interim Order and Files Management Information Circular in Connection with Special Meeting of Shareholders
November 2, 2023
Read more
OpSens Announces the Positive Clinical Results from the SAFE-TAVI with SavvyWire in Europe
October 23, 2023
Read more
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 – 26, 2023
October 17, 2023
Read more
OpSens signs definitive agreement for its acquisition by Haemonetics
October 10, 2023
Read more
OpSens Announces a third Consecutive Quarter of Record Revenues for Third Quarter Fiscal 2023
July 13, 2023
Read more
OpSens to Host Third Quarter Fiscal Year 2023 Financial Results Conference Call on Thursday July 13, 2023
July 6, 2023
Read more
OpSens Announces Inclusion of SavvyWire in COMPLETE TAVR Study
May 10, 2023
Read more
OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 20, 2023
Read more
OpSens Announces Record Revenue for Second Quarter Fiscal 2023
April 13, 2023
Read more
OpSens Announces Completion of Enrollment in SAFE-TAVI Study With SavvyWire in Europe
April 11, 2023
Read more
OpSens to Host Second Quarter FY 2023 Financial Results Conference Call
April 6, 2023
Read more
OpSens Announces 1,000th SavvyWire® Procedure
April 5, 2023
Read more
OpSens Appoints John Hannigan as Chief Financial Officer
March 27, 2023
Read more
OpSens Awarded Interventional Specialty Diagnostics Agreement With Premier for SavvyWire™
March 14, 2023
Read more
OpSens Announces SavvyWire™ Used During Two Live Cases at CRT Conference
February 28, 2023
Read more
OpSens to Participate in the Lytham Partners Investor Select Conference, January 31st and February 1st
January 25, 2023
Read more
OpSens Announces Record First Quarter fiscal 2023 Financial Results
January 12, 2023
Read more
OpSens to Host First Quarter FY 2023 Financial Results Conference Call
January 5, 2023
Read more

Press releases 2022

OpSens Announces Filing of Preliminary Base Shelf Prospectus
December 22, 2022
Read more
OpSens Announces Closing of $11.5 Million Bought Deal Public Offering Including $1.5 Million Over-Allotment Option Exercised in Full
December 22, 2022
Read more
OpSens Announces $10 Million Bought Deal Offering
December 1, 2022
Read more
OpSens Announces First SavvyWire Procedure in New Zealand
November 29, 2022
Read more
OpSens Announces Fourth Quarter and Fiscal Year 2022 Financial Results
November 22, 2022
Read more
OpSens to Host Fourth Quarter Fiscal Year 2022 Financial Results Conference Call and Year-End Update on November 22, 2022
November 16, 2022
Read more
OpSens Announces Departure of CFO
November 1, 2022
Read more
OpSens Announces First SavvyWire Clinical Cases in Europe and Launch of SAFE-TAVI Study
October 26, 2022
Read more
OpSens Announces First SavvyWire Procedure in the U.S. by Dr. Philippe Genereux of Morristown Medical Center
September 23, 2022
Read more
OpSens Announces FDA Clearance for the SavvyWire™ for Use in Transcatheter Aortic Valve Replacement (TAVR) Procedures
September 15, 2022
Read more
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in Boston September 16-19, 2022
September 14, 2022
Read more
OpSens Announces Third Quarter Fiscal 2022 Financial Results With Record Quarterly Revenues
July 14, 2022
Read more
OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III
July 11, 2022
Read more
OpSens to Host Third Quarter Fiscal Year 2022 Financial Results Conference Call on Thursday, July 14
July 7, 2022
Read more
OpSens Announces Global SavvyWire™ First Commercial Use
June 7, 2022
Read more
OpSens SavvyWire™ First-in-Human Results Presented at Europcr in Paris and Simultaneously Published in EuroIntervention Journal
May 19, 2022
Read more
OpSens Announces Publication in JSCAI – Data Supporting the Correlation Between the OptoWire and a Novel TAVR Interface with Standard of Care, Before and After TAVR
May 18, 2022
Read more
OpSens Announces Health Canada Approval For Its New TAVR Guidewire
April 26, 2022
Read more
OpSens Announces Second Quarter Fiscal 2022 Financial Results
April 13, 2022
Read more
OpSens to Host Second Quarter FY 2022 Financial Results Conference Call on Wednesday April 13
April 6, 2022
Read more
OpSens to Participate in the 32nd Annual Oppenheimer Healthcare Conference March 15th to 17th
March 14, 2022
Read more
OpSens Appoints Brad Davis as New Chief Commercial Officer
February 9, 2022
Read more
OpSens Announces Abiomed 4-year Supply Agreement Extension to 2028
February 1, 2022
Read more
OpSens Named to 2022 OTCQX Best 50
January 24, 2022
Read more
OpSens Announces First Quarter Fiscal 2022 Financial Results
January 13, 2022
Read more
OpSens to Host First Quarter FY 2022 Financial Results Conference Call on Thursday, January 13, 2022
January 6, 2022
Read more

Press releases 2021

OpSens Announces 510(K) Submission to U.S. FDA for New Guidewire for the TAVR Procedure
December 13, 2021
Read more
OpSens to Present at the Lytham Partners Winter 2021 Investor Conference Presentation at 11 AM (ET), Monday December 13, 2021
December 7, 2021
Read more
OpSens Announces Fourth Quarter And Fiscal Year 2021 Financial Results
November 23, 2021
Read more
OpSens Successfully Completes 20-Patient In-Human Clinical Study for TAVR Procedure
November 23, 2021
Read more
OpSens to Host Fourth Quarter Fiscal Year 2021 Financial Results Conference Call and Year-End Update on Tuesday, November 23, 2021
November 17, 2021
Read more
OpSens Will Participate at Stifel 2021 Virtual Healthcare Conference and Canaccord Genuity  MedTech & Diagnostics Forum
November 10, 2021
Read more
OpSens’ SavvyWire™ Featured at the Transcatheter Cardiovascular Therapeutics 2021 Annual Meeting in Orlando
November 8, 2021
Read more
OpSens Successfully Treats First Patients in Human Clinical Study for TAVR Procedure
October 13, 2021
Read more
OpSens to Present at the Lytham Partners Fall 2021 Investor Conference – Tuesday, October 5, 2021, 9:30 AM
September 29, 2021
Read more
OpSens Receives Approval from Health Canada to Initiate First In-Man Study For its New Guidewire For the TAVR Procedure
September 20, 2021
Read more
OpSens Appoints Lori Chmura to its Board of Directors
September 8, 2021
Read more
OpSens Announces Third Quarter Fiscal 2021 Record Financial Results
July 13, 2021
Read more
OpSens to Host Third Quarter Fiscal Year 2021 Financial Results Conference Call on Tuesday, July 13
July 7, 2021
Read more
OpSens Solutions Receives Funding Support to Jointly Develop an Optical-Based Fuel Monitoring System for Aerospace Applications, Including Civil Aircrafts
June 16, 2021
Read more
OpSens Will Participate and Present at Two Investment Conferences Lytham Partners and Raymond James
June 9, 2021
Read more
OpSens to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
May 13, 2021
Read more
OpSens Integrates its OptoWire’s dPR and FFR Algorithms within Cathmedical Cardiovascular’s Picasso System in Spain
April 21, 2021
Read more
OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues
April 14, 2021
Read more
OpSens Awarded Innovative Technology Contract by Vizient for OptoWire III
April 7, 2021
Read more
OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 – Conference call to be conducted at 11:00 am ET
April 6, 2021
Read more
OpSens to Present at Lytham Partners Spring 2021 Investor Conference – Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021
March 22, 2021
Read more
OpSens: Closing of $28.75 M Bought Deal Public Offering – Including $3.75 M Over-Allotment Option Exercised in Full
February 25, 2021
Read more
OpSens Obtains CE Marking for the OptoWire III
February 18, 2021
Read more
OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)
February 8, 2021
Read more
OpSens Announces $25 Million Bought Deal Offering
February 5, 2021
Read more
OpSens Announces First Quarter fiscal 2021 financial Results
January 13, 2021
Read more
OpSens to Host First Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, January 13, 2021
January 6, 2021
Read more

Press releases 2020

OpSens to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 24, 2020
Read more
OpSens announces fourth quarter and fiscal year 2020 results
November 19, 2020
Read more
OpSens recognized as one of the Fastest-Growing Companies in North America on Deloitte’s 2020 Technology Fast 500™
November 18, 2020
Read more
OpSens to Present at the Virtual Fall Investor Summit On November 16
November 13, 2020
Read more
OpSens to Host Year-End Update Conference Call on Thursday, November 19, 2020
November 12, 2020
Read more
OpSens to Present at the Virtual Fall Investor Summit On November 16
November 10, 2020
Read more
OpSens Awarded Contract by Major U.S. Group Purchasing Organization
October 14, 2020
Read more
OpSens to Present at Lytham Partners Virtual Investor Growth Conference
September 30, 2020
Read more
OpSens to Present at the LD 500 Virtual Conference
August 26, 2020
Read more
OpSens Announces Q3 Results 2020
July 15, 2020
Read more
Opsens – 100,000 Cases Performed with the OptoWire
May 20, 2020
Read more
OpSens at C-Suite at the Open
April 27, 2020
Read more
OpSens – Message to the medical community, Covid-19
April 9, 2020
Read more
OpSens Announces Q2 2020 Results
April 9, 2020
Read more
OPSENS PROVIDES OPERATIONAL UPDATE – Continues to supply essential cardiovascular solutions to patients around the world
March 24, 2020
Read more
Opsens receives FDA approval of OptoWire III – Improved handling and lower cost of production
January 13, 2020
Read more
OpSens Announces Q1 2020 Results
January 13, 2020
Read more

Press releases 2019

OPSENS RECEIVES dPR CLEARANCE FROM FDA
December 19, 2019
Read more
OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41%
November 14, 2019
Read more
OPSENS – FIRST CLINICAL USE OF OPTOWIRE III AFTER HEALTH CANADA APPROVAL
November 7, 2019
Read more
OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET
November 5, 2019
Read more
OPSENS SOLUTIONS – STRATEGIC ORDER FOR FIBER OPTIC SENSORS TO BE DEPLOYED IN NEW INDUSTRIAL DEWATERING PROCESS
July 16, 2019
Read more
OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%
July 11, 2019
Read more
OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER
June 17, 2019
Read more
OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT
June 11, 2019
Read more
OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL
May 22, 2019
Read more
OPSENS SIGNS LANDMARK SUPPLIER AGREEMENT – EXPANDS OPTICAL SENSING TECHNOLOGY IMPACT WITHIN CARDIOLOGY SEGMENT
April 30, 2019
Read more
OPSENS – Q2 2019 REVENUES REACH $7.9 M, A 46% INCREASE
April 11, 2019
Read more
OPSENS APPOINTS ALAN MILINAZZO AS EXECUTIVE CHAIRMAN OF THE BOARD OF DIRECTORS
March 4, 2019
Read more
OPSENS ANNOUNCES CREDIT AGREEMENT WITH CIBC INNOVATION BANKING
February 27, 2019
Read more
OPSENS – Q1 2019 REVENUES REACH A RECORD HIGH OF $9.1 M, A 43% INCREASE
January 14, 2019
Read more
OPSENS’ dPR OBTAINS CE MARKING TO SELL IN EUROPE
January 9, 2019
Read more

Press releases 2018

OPSENS REPORTS Q4 and FY2018 RESULTS – RECORD ANNUAL REVENUE SURPASS $24 M AND RECORD QUARTERLY FFR REVENUES AT $4.1 M
November 28, 2018
Read more
OPSENS RECEIVES HEALTH CANADA APPROVAL FOR dPR INTENDED FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST
November 27, 2018
Read more
OPSENS – FIRST USE OF dPR FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST
November 8, 2018
Read more
OPSENS – 50,000 PATIENTS DIAGNOSED WITH THE OPTOWIRE
November 1, 2018
Read more
OPSENS TO HOST INVESTOR WEBINAR ON THURSDAY, OCTOBER 4 TO PROVIDE UPDATE ON RECENT DEVELOPMENTS
October 3, 2018
Read more
OPSENS – NEW PRODUCT FOR THE DIAGNOSIS OF CORONARY STENOSIS WITH THE HEART AT REST
September 20, 2018
Read more
OPSENS REPORTS Q3 2018 RESULTS – Quarterly Revenues Eclipse $6.4 M
July 12, 2018
Read more
OPSENS APPLAUDS JAPANESE GOVERNMENT NEW REGULATION SUPPORTING DIAGNOSIS, SUCH AS FFR, BEFORE TREATMENT OF CORONARY STENOSIS
April 24, 2018
Read more
OPSENS REPORTS Q2 2018 RESULTS – CONSOLIDATED PRODUCT SALES UP 44%
April 12, 2018
Read more
OPSENS’ TECHNOLOGY GRANTED FDA APPROVAL IN ABIOMED’S IMPELLA CARDIAC PUMP®
April 3, 2018
Read more
OPSENS ANNOUNCES ELECTION RESULTS FOR THE BOARD OF DIRECTORS AND THE RETIREMENT OF CLAUDE BELLEVILLE
January 23, 2018
Read more
OPSENS REPORTS Q1 2018 RESULTS – RECORD QUARTERLY REVENUES WITH GROWTH IN ALL GEOGRAPHIC REGIONS
January 16, 2018
Read more

Press releases 2017

OPSENS’ JAPANESE PARTNER ZEON MEDICAL PROCEEDS WITH CONVERSION OF US$2 MILLION DEBENTURE
November 27, 2017
Read more
OPSENS REPORTS 2017 RESULTS – CONSOLIDATED REVENUES UP 85% FOR FISCAL 2017
November 15, 2017
Read more
OPSENS GETS TECHNOLOGICAL AWARD
October 24, 2017
Read more
OPSENS PRESENTS A SHORT FILM AT THE INTERNATIONAL MEDICAL FILM FESTIVAL
September 19, 2017
Read more
Opsens – Q3 Results
June 29, 2017
Read more
ROBIN VILLENEUVE APPOINTED AS CHIEF FINANCIAL OFFICER
June 7, 2017
Read more
OPSENS ANNOUNCES DEPARTURE OF CFO
May 5, 2017
Read more
OPSENS REPORTS Q2 2017 RESULTS – QUARTERLY CONSOLIDATED REVENUES UP 75% TO $4.8 MILLION
April 19, 2017
Read more
OPSENS ANNOUNCES GRADUATION TO TSX
February 28, 2017
Read more
OPSENS REPORTS Q1 2017 RESULTS – FOCUSED EXECUTION LEADS TO RECORD QUARTERLY REVENUES
January 26, 2017
Read more

Press releases 2016

OPSENS INC. COMPLETES A $14.95 MILLION EQUITY FINANCING BY WAY OF PROSPECTUS
December 8, 2016
Read more
OPSENS ANNOUNCES UPSIZE TO AND PROVIDES ADDITIONAL DETAILS REGARDING ITS PROPOSED EQUITY FINANCING
November 23, 2016
Read more
Opsens Announces Equity Financing
November 23, 2016
Read more
OPSENS REPORTS RESULTS FOR 2016 – RECORD TOTAL REVENUES DRIVEN BY TENFOLD INCREASE IN FFR SALES
November 16, 2016
Read more
OPSENS RECEIVES 510(K) CLEARANCE FOR THE OPTOMONITOR II PROVIDING EXTENDED INDICATION
September 26, 2016
Read more
OPSENS ANNOUNCES PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES IN THE ENERGY SECTOR
September 22, 2016
Read more
OPSENS APPOINTS PAT MACKIN TO ITS BOARD OF DIRECTORS
September 7, 2016
Read more
CIRCULATION JOURNAL HIGHLIGHTS OPTOWIRE PERFORMANCE
August 31, 2016
Read more
OPSENS Q3 RESULTS – SALES OF $2,125,000, UP 156% YEAR-OVER-YEAR
July 5, 2016
Read more
OPSENS: HEALTH CANADA APPROVAL FOR THE SALE OF OPTOWIRE II
June 22, 2016
Read more
OPSENS COMPLETES $5 MILLION PRIVATE PLACEMENT
May 17, 2016
Read more
OPSENS ANNOUNCES RESULTS FOR ITS SECOND QUARTER 2016
April 21, 2016
Read more
OPSENS RECEIVES FDA 510(K) CLEARANCE FOR THE OPTOWIRE II
March 16, 2016
Read more
OPSENS NAMED TO THE 2016 TSX VENTURE TOP 50®
March 10, 2016
Read more
OPSENS HIRES GEORGE QUINOY AS VP/GM U.S. COMMERCIAL SALES & OPERATIONS
January 25, 2016
Read more
OPSENS REPORTS Q1 2016 RESULTS
January 19, 2016
Read more

Press releases 2015

OPSENS COMPLETES A $5 M FINANCING
December 22, 2015
Read more
OPSENS – DETAILS ON PROPOSED FINANCING
December 3, 2015
Read more
OPSENS ANNOUNCES EQUITY FINANCING
December 3, 2015
Read more
$1.2 M ORDERS FOR OPSENS’ FFR PRODUCTS
November 30, 2015
Read more
OPSENS GRANTED APPROVAL TO SELL OPTOWIRE II IN JAPAN
November 26, 2015
Read more
OPSENS REPORTS 2015 RESULTS
November 24, 2015
Read more
OPSENS APPROVED TO SELL OPTOWIRE II IN EUROPE
November 12, 2015
Read more
Opsens – First use of its FFR products in the U.S.
November 12, 2015
Read more
Opsens – 1,000th procedure with the OptoWire
November 12, 2015
Read more
OPSENS TO PRESENT LIVE VIA WEBCAST AT VIRTUALINVESTORCONFERENCES.COM ON OCTOBER 1, 2015 AT 9:15AM ET
September 29, 2015
Read more
OPSENS HIRES TONY GIBBONS AS VICE PRESIDENT, SALES AND MARKETING
September 16, 2015
Read more
OPSENS ANNOUNCES THE RESIGNATION OF A DIRECTOR
September 16, 2015
Read more
Opsens Announces a Reorganization of its Corporate Structure
September 3, 2015
Read more
OPSENS ANNOUNCES AN ENERGY SECTOR PARTNERSHIP WITH PRECISE DOWNHOLE SERVICES
August 28, 2015
Read more
OPSENS RECEIVES HEALTH CANADA APPROVAL TO COMMERCIALIZE ITS FFR PRODUCTS
July 21, 2015
Read more
OPSENS – RESULTS FOR THIRD QUARTER 2015
July 2, 2015
Read more
OPSENS MOVES FFR ACTIVITIES TO INCREASE MANUFACTURING CAPACITY
June 17, 2015
Read more
OPSENS GETS CLEARANCE TO SELL FFR PRODUCTS IN THE UNITED STATES
June 15, 2015
Read more
OPSENS ANNOUNCES FIRST USE OF ITS FFR PRODUCTS BY DR. NICO PIJLS
May 20, 2015
Read more
OPSENS – SECOND QUARTER 2015 RESULTS
April 21, 2015
Read more
OPSENS’ SHARES NOW TRADED ON THE OTCQX MARKETPLACE IN U.S.
March 31, 2015
Read more
Opsens appoints Denis Harrington to its Board of Directors
January 20, 2015
Read more
Opsens – results of first quarter 2015
January 19, 2015
Read more

Press Releases 2013

2013-11-26 Opsens reports fourth quarter results Read more
2013-11-13 Opsens ranks on Deloitte’sTechnology Fast 50 program Read more
2013-07-04 Opsens reports third quarter results Read more
2013-06-03 Opsens On Profit 500 Read more
2013-04-23 Opsens releases Q2 Read more
2013-04-19 OPSENS PARTICIPATES IN GOLDMAN SACHS EMERGING HEALTHCARE SERIES Read more
2013-03-12 OPSENS RECEIVES LARGEST-EVER ORDER FOR ITS OPP-W FIBER OPTIC PRESSURE AND TEMPERATURE SENSORS Read more
2013-02-20 Opsens Successfully Deploys A Pressure and Temperature System on PTRC’S Aquistore Project, Saskatchewan, Canada Read more
2013-01-22 Opsens reaches profitability in Q1 Read more
2013-01-07 Changes at senior management level Read more

Press Releases 2012

2012-11-27 Opsens announces highest revenue ever in FY2012 Read more
2012-11-19 Opsens signs a distribution agreement for its FFR products in Asia in a US$ 5million transaction Read more
2012-07-04 Q3 Results Read more
2012-04-24 Q2 Results – 78% Revenue Increase Read more
2012-03-02 OPSENS SETTLES FFR LAWSUIT Read more
2012-01-17 Q1 results – 118% revenue increase Read more

Press Releases 2011

2011-11-15 Opsens – Q4 Results Read more
2011-10-17 Opsens – Canadian Patent for the EasyWire for FFR Read more
2011-10-12 MULTI-WELL ORDER TO INSTRUMENT HIGH-TEMPERATURE RESERVOIRS WITH OPP-W SENSORS AND DTS Read more
2011-09-13 Opsens receives ISO 13485 certification for FFR Read more
2011-09-06 Opsens and Lios sign agreement Read more
2011-07-26 OPSENS RECEIVES SECOND COMMERCIAL ORDER FOR ITS OPP-W FIBER OPTIC PRESSURE SENSORS – 21 WELLS FROM MAJOR ALBERTA OIL PRODUCER Read more
2011-07-05 OPSENS REPORTS Q3 2011 RESULTS WITH BEST-EVER QUARTERLY REVENUE Read more
2011-06-07 OPSENS WINS ORDER TO INSTRUMENT HIGH-TEMPERATURE WELLS FOR SAGD PRODUCER Read more
2011-04-19 Opsens – Q2 Read more
2011-03-09 OPSENS WILL STRONGLY DEFEND AGAINST ACIST LAWSUIT Read more
2011-02-23 Opsens – EasyWire & OptoWire, preclinical trials Read more
2011-01-21 Opsens reports Q1 results Read more
2011-01-12 OPP-W and DTS combination order for multi-zone observation well from new client Read more
2011-01-10 Opsens unveils second medical device for FFR market Read more

Press Releases 2010

2010-12-20 Opsens unveils medical device for FFR market Read more
2010-12-07 Orders for OPP-W sensors associated with DTS Read more
2010-11-18 OPSENS ANNOUNCES 71% SALES GROWTH FOR 2010 Read more
2010-10-19 New client orders OPP-W in Alberta Read more
2010-09-29 Opsens selected to design and produce well integrity tool Read more
2010-09-01 Opsens – New President for Opsens Solutions Read more
2010-08-31 Opsens appoints three directors Read more
2010-08-17 Opsens transfers transformers business to LumaSense Read more
2010-07-07 Opsens reports Q3 2010 results with best-ever quarterly revenue Read more
2010-05-06 Opsens gets additional orders for reservoir surveillance systems for CO2-EOR project Read more
2010-04-21 Opsens reports second quarter results Read more
2010-04-06 Opsens receives follow-on order from OPP-W customer Read more
2010-02-12 Opsens announces closing of private placement Read more
2010-02-05 Opsens named as part of 2010 TSX venture 50 Read more
2010-02-01 Opsens announces private placement Read more
2010-01-27 Abiomed announces partnership with Opsens to utilize sensor technology for Impella Read more
2010-01-20 Opsens reports first quarter 2010 results Read more

Press Releases 2009

2009-11-23 Opsens announces order from a large integrated oil company for casing-conveyed permanent observation well in co2-eor project Read more
2009-11-18 Opsens reports FY 2009 results Read more
2009-10-15 Opsens receives multi-well order for fiber optic pressure sensors from major Alberta oil producer. Read more
2009-07-08 Opsens receives grant from NRC-IRAP to develop new medical device. Read more
2009-07-07 Opsens reports 3Q results – Quarterly revenue exceed $1 million Read more
2009-06-25 Opsens announces closing of $1.75 million private placement. Read more
2009-06-19 OPSENS announces $2 million private placement Read more
2009-05-08 OPP-W sensors withstand the test of time in extremely harsh down-hole oilfield environment. Read more
2009-04-22 Opsens reports 2Q results, including a record backlog Read more
2009-03-03 Opsens sells 60 PowerSens II systems to power company Read more
2009-02-27 Opsens announces repeat order from a large integrated oil company for multi-well installation of fiber optic sensors Read more
2009-02-10 Opsens launches new miniature pressure sensor for life sciences & medical devices Read more
2009-02-02 Opsens launches new signal conditioner for power transformer sector Read more
2009-01-21 Opsens announces results for first quarter of 2009 Read more

Press Releases 2008

2008-12-01 Opsens announces order repeat from oil sands client Read more
2008-11-20 Opsens receives sensor order from major canadian oil sands operator. Read more
2008-11-20 Opsens announces fourth quarter and FY2008 results. Read more
2008-10-20 Opsens inc. receives ISO 9001:2000 certification. Read more
2008-07-04 Opsens inc. announces 376% sales growth for third quarter 2008 Read more
2008-04-23 Opsens inc. announces 140% sales growth for second quarter 2008. Read more
2008-04-08 Opsens inc. announces closing $3,8 million brokered private placement. Read more
2008-03-26 Opsens inc. announces CAD$4,00 million brokered private placement. Read more
2008-01-22 Opsens inc. announces 327 % sales growth for first quarter 2008. Read more
2008-01-09 Opsens inc. announces two new orders in the Oil & Gas. Read more

Press Releases 2007

2007-12-12 Opsens inc. concludes the acquisition of Inflo Solutions in Alberta to integrate its operations in Oil & Gas. Read more
2007-11-28 Opsens inc. publishes its annuel results for the fiscal year ended August 31, 2007 and sees record level order backlog. Read more
2007-11-21 Opsens inc. announces an order from a european medical customer. Read more
2007-11-05 Opsens inc. announces $6,25 million private placement. Read more
2007-10-29 Opsens inc. receives first order from japanese manufacturer for cardiovascular pressure measurement. Read more
2007-10-24 Opsens inc. announces new orders from the EED market on three continents. Read more
2007-10-17 Opsens inc. announces an order from BAE Systems. Read more
2007-10-16 Opsens’ RadSens System accepted for RADHAZ Applications by the United Kingdom MoD DOSG. Read more
2007-08-21 USPTO grants a patent on main Opsens technology. Read more
2007-08-13 Opsens inc. completes with success the evaluation of its signal conditioner from an european medical customer. Read more
2007-07-04 Opsens inc. announces its financial results for the quarter ended May 31, 2007. Read more
2007-05-15 Opsens inc. completes an important milestone in its history with an order received from a major oil sands operator in Alberta for the supply and installation of its optical sensing systems. Read more
2007-04-25 Opsens inc. announces the nomination to its advisory committee of Maurice B. Dusseault, well-known expert in heavy oil and oil sands production processes. Read more
2007-04-24 Opsens inc. announces its financial results for the quarter ended February 28, 2007. Read more
2007-04-16 Opsens inc. names Yves Plamondon as vice president sales & marketing. Read more
2007-03-22 Opsens inc. announces an order from a high-potential client in the medical indus Read moretry.
2007-01-25 Opsens inc. announces its financial results for the quarter ended November 30, 2006. Read more

Press Releases 2006

2006-12-05 Opsens inc. closes a private placement with a premier US financial institution and a private investor for an amount of $1,100,000. Read more
2006-10-11 Opsens Inc. closes a second private placement of $1,175,000 for a total aggregate private placement of $2,215,000 Read more
2006-10-03 Opsens Inc. closes a qualifying transaction with DCB Capital Inc. and closes a private placement of $1,040,000 Read more

* Links to third party sites are for informational purposes only. Opsens Inc. have not prepared, reviewed or updated any content on third party sites and assume no responsibility for the information posted on them.